| 1. |
- Rinne, J., et al.
(författare)
-
Effect of the 2018 European drought on methane and carbon dioxide exchange of northern mire ecosystems
- 2020
-
Ingår i: Philosophical Transactions of the Royal Society B-Biological Sciences. - : The Royal Society. - 0962-8436 .- 1471-2970. ; 375:1810
-
Tidskriftsartikel (refereegranskat)abstract
- We analysed the effect of the 2018 European drought on greenhouse gas (GHG) exchange of five North European mire ecosystems. The low precipitation and high summer temperatures in Fennoscandia led to a lowered water table in the majority of these mires. This lowered both carbon dioxide (CO2) uptake and methane (CH4) emission during 2018, turning three out of the five mires from CO(2)sinks to sources. The calculated radiative forcing showed that the drought-induced changes in GHG fluxes first resulted in a cooling effect lasting 15-50 years, due to the lowered CH(4)emission, which was followed by warming due to the lower CO(2)uptake. This article is part of the theme issue 'Impacts of the 2018 severe drought and heatwave in Europe: from site to continental scale'.
|
|
| 2. |
|
|
| 3. |
- Kallionpaa, R. A., et al.
(författare)
-
Increased risk for dementia in neurofibromatosis type 1
- 2021
-
Ingår i: Genetics in Medicine. - : Elsevier BV. - 1098-3600.
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose To determine the risk for dementia in neurofibromatosis type 1 (NF1) using a Finnish nationwide cohort of individuals with NF1, and data from national registries. Methods A Finnish cohort of 1,349 individuals with confirmed NF1 according to the US National Institutes of Health (NIH) diagnostic criteria was compared with a control cohort of 13,870 individuals matched for age, sex, and area of residence. Dementia-related hospital visits were retrieved from the Finnish Care Register for Health Care using International Classification of Diseases, 10th revision (ICD-10) diagnosis codes G30 and F00-F03. Purchases of antidementia drugs were queried with Anatomical Therapeutic Chemical (ATC) classification code N06D from the drug reimbursement register maintained by the Social Insurance Institution of Finland. The follow-up spanned 1998-2014. Results Totals of 16 and 165 individuals with at least two dementia-related diagnoses or drug purchases were identified in the NF1 and control cohorts, respectively. The hazard ratio for dementia in NF1 was 1.67 (95% confidence interval [CI] 1.00-2.80, P = 0.050). In an analysis stratified by the type of dementia, the risk for Alzheimer disease was increased in NF1 compared to controls with a hazard ratio of 2.88 (95% CI 1.47-5.66, P = 0.002). Conclusion Dementia and especially Alzheimer disease are previously unrecognized neurological complications of NF1.
|
|
| 4. |
|
|
| 5. |
- Svenningsson, P., et al.
(författare)
-
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
- 2020
-
Ingår i: Movement Disorders. - : Wiley. - 0885-3185 .- 1531-8257. ; 35:6, s. 1046-1054
-
Tidskriftsartikel (refereegranskat)abstract
- Background IRL752 is a novel small-molecule compound that acts to regioselectively enhance norepinephrine, dopamine, and acetylcholine neurotransmission in the cerebral cortex. Objective The primary objective of the trial was to investigate the safety and tolerability of IRL752 in patients with Parkinson's disease and dementia. Methods Patients with Parkinson's disease and dementia were randomized to IRL752 or placebo treatment (3:1 ratio) for 28 days. The study drug was given as an adjunct treatment to the patients' regular stable antiparkinsonian medication. Dosing was individually titrated for 14 days after which the dose was kept stable for an additional 14 days. Results A total of 32 patients were randomized to treatment, and 29 patients completed the 4-week treatment. Adverse events were generally mild and transient and were mostly reported during the dose titration phase. There were 2 serious adverse events, and none of them were related to the experimental treatment. The average dose achieved in the stable dose phase was 600 mg daily, yielding a 2-hour postdose plasma concentration of about 4 mu M on day 28. Exploratory assessment of secondary outcomes indicated efficacy for symptoms and signs known to be poorly responsive to levodopa. Conclusions IRL752 appears to be safe and well tolerated for a 4-week treatment in patients with Parkinson's disease and dementia. (c) 2020 International Parkinson and Movement Disorder Society
|
|
| 6. |
- Chang, Kuang Yu, et al.
(författare)
-
Substantial hysteresis in emergent temperature sensitivity of global wetland CH4 emissions
- 2021
-
Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 12:1, s. 2266-2266
-
Tidskriftsartikel (refereegranskat)abstract
- Wetland methane (CH4) emissions ([Formula: see text]) are important in global carbon budgets and climate change assessments. Currently, [Formula: see text] projections rely on prescribed static temperature sensitivity that varies among biogeochemical models. Meta-analyses have proposed a consistent [Formula: see text] temperature dependence across spatial scales for use in models; however, site-level studies demonstrate that [Formula: see text] are often controlled by factors beyond temperature. Here, we evaluate the relationship between [Formula: see text] and temperature using observations from the FLUXNET-CH4 database. Measurements collected across the globe show substantial seasonal hysteresis between [Formula: see text] and temperature, suggesting larger [Formula: see text] sensitivity to temperature later in the frost-free season (about 77% of site-years). Results derived from a machine-learning model and several regression models highlight the importance of representing the large spatial and temporal variability within site-years and ecosystem types. Mechanistic advancements in biogeochemical model parameterization and detailed measurements in factors modulating CH4 production are thus needed to improve global CH4 budget assessments.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Räsänen, Matti, et al.
(författare)
-
Root-zone soil moisture variability across African savannas : From pulsed rainfall to land-cover switches
- 2020
-
Ingår i: Ecohydrology. - : Wiley. - 1936-0584 .- 1936-0592. ; 13:5
-
Tidskriftsartikel (refereegranskat)abstract
- The main source of soil moisture variability in savanna ecosystems is pulsed rainfall. Rainfall pulsing impacts water-stress durations, soil moisture switching between wet-to-dry and dry-to-wet states, and soil moisture spectra as well as derived measures from it such as soil moisture memory. Rainfall pulsing is also responsible for rapid changes in grassland leaf area and concomitant changes in evapotranspirational (ET) losses, which then impact soil moisture variability. With the use of a hierarchy of models and soil moisture measurements, temporal variability in root-zone soil moisture and water-stress periods are analysed at four African sites ranging from grass to miombo savannas. The normalized difference vegetation index (NDVI) and potential ET (PET)-adjusted ET model predict memory timescale and dry persistence in agreement with measurements. The model comparisons demonstrate that dry persistence and mean annual dry periods must account for seasonal and interannual changes in maximum ET represented by NDVI and to a lesser extent PET. Interestingly, the precipitation intensity and soil moisture memory were linearly related across three savannas with ET/infiltration ∼ 1.0. This relation and the variability of length and timing of dry periods are also discussed.
|
|
